AAAAAA
Results:
1-24
|
Results: 24
Authors:
ELLIOTT MA
CHEN MG
SILVERSTEIN MN
TEFFERI A
Citation: Ma. Elliott et al., SPLENIC IRRADIATION FOR SYMPTOMATIC SPLENOMEGALY ASSOCIATED WITH MYELOFIBROSIS WITH MYELOID METAPLASIA, British Journal of Haematology, 103(2), 1998, pp. 505-511
Authors:
PETRONE ME
TIERNEY DS
MAHONEY MP
PETITT RM
SILVERSTEIN MN
Citation: Me. Petrone et al., ANAGRELIDE FOR TREATMENT OF HIGH PLATELET COUNT IN PATIENTS WITH POLYCYTHEMIA-VERA, British Journal of Haematology, 102(1), 1998, pp. 308-308
Authors:
TEFFERI A
SILVERSTEIN MN
Citation: A. Tefferi et Mn. Silverstein, AGNOGENIC MYELOID METAPLASIA, Cancer investigation, 15(2), 1997, pp. 177-179
Authors:
TEFFERI A
ELLIOTT MA
SOLBERG LA
SILVERSTEIN MN
Citation: A. Tefferi et al., NEW DRUGS IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA-VERA, Blood reviews, 11(1), 1997, pp. 1-7
Authors:
PETITT RM
SILVERSTEIN MN
PETRONE ME
Citation: Rm. Petitt et al., ANAGRELIDE FOR CONTROL OF THROMBOCYTHEMIA IN POLYCYTHEMIA AND OTHER MYELOPROLIFERATIVE DISORDERS, Seminars in hematology, 34(1), 1997, pp. 51-54
Authors:
TEFFERI A
SILVERSTEIN MN
LI CY
Citation: A. Tefferi et al., 2-CHLORODEOXYADENOSINE TREATMENT AFTER SPLENECTOMY IN PATIENTS WHO HAVE MYELOFIBROSIS WITH MYELOID METAPLASIA, British Journal of Haematology, 99(2), 1997, pp. 352-357
Authors:
SOLBERG LA
TEFFERI A
OLES KJ
TARACH JS
PETITT RM
FORSTROM LA
SILVERSTEIN MN
Citation: La. Solberg et al., THE EFFECTS OF ANAGRELIDE ON HUMAN MEGAKARYOCYTOPOIESIS, British Journal of Haematology, 99(1), 1997, pp. 174-180
Authors:
ELLIOTT MA
CHEN MG
SILVERSTEIN MN
TEFFERI A
Citation: Ma. Elliott et al., SPLENIC IRRADIATION FOR SYMPTOMATIC SPLENOMEGALY ASSOCIATED WITH MYELOFIBROSIS WITH MYELOID METAPLASIA (MMM), Blood, 90(10), 1997, pp. 1545-1545
Authors:
FAIRBANKS VF
KLEE GG
WISEMAN GA
HOYER JD
TEFFERI A
PETITT RM
SILVERSTEIN MN
Citation: Vf. Fairbanks et al., MEASUREMENT OF BLOOD-VOLUME AND RED-CELL MASS - REEXAMINATION OF CR-51 AND I-125 METHODS, Blood cells, molecules, & diseases, 22(15), 1996, pp. 169-186
Authors:
FAIRBANKS VF
KLEE GG
WISEMAN GA
HOYER JD
TEFFERI A
PETITT RM
SILVERSTEIN MN
Citation: Vf. Fairbanks et al., MEASUREMENT OF BLOOD-VOLUME AND RED-CELL MASS - REEXAMINATION OF CR-51 AND I-125 METHODS (CORRECTED VERSION OF VC666), Blood cells, molecules, & diseases, 22(15), 1996, pp. 169-186
Authors:
TEFFERI A
SILVERSTEIN MN
Citation: A. Tefferi et Mn. Silverstein, CURRENT PERSPECTIVE IN AGNOGENIC MYELOID METAPLASIA, Leukemia & lymphoma, 22, 1996, pp. 169-171
Authors:
SILVERSTEIN MN
PETRONE ME
PETITT RM
DEMENT MP
VUKOVICH RA
Citation: Mn. Silverstein et al., THE SAFETY PROFILE OF ANAGRELIDE FOR TREATMENT OF THROMBOCYTHEMIA, Blood, 88(10), 1996, pp. 2321-2321
Authors:
TEFFERI A
SILVERSTEIN MN
NOEL P
Citation: A. Tefferi et al., AGNOGENIC MYELOID METAPLASIA, Seminars in oncology, 22(4), 1995, pp. 327-333
Authors:
TEFFERI A
SILVERSTEIN MN
HOAGLAND HC
Citation: A. Tefferi et al., PRIMARY THROMBOCYTHEMIA, Seminars in oncology, 22(4), 1995, pp. 334-340
Authors:
TEFFERI A
SILVERSTEIN MN
LI CY
Citation: A. Tefferi et al., 2-CHLORODEOXYADENOCINE (2CDA) TREATMENT IN MYELOFIBROSIS WITH MYELOIDMETAPLASIA (MMM), Blood, 86(10), 1995, pp. 179-179
Authors:
SILVERSTEIN MN
TEFFERI A
LI CY
PETITT RM
Citation: Mn. Silverstein et al., A PILOT-STUDY OF ANAGRELIDE FOR THE TREATMENT OF MYELOFIBROSIS WITH MYELOID METAPLASIA (MMM), Blood, 86(10), 1995, pp. 3195-3195
Authors:
BERESSI AH
TEFFERI A
SILVERSTEIN MN
PETITT RM
HOAGLAND HC
Citation: Ah. Beressi et al., OUTCOME ANALYSIS OF 34 PREGNANCIES IN WOMEN WITH ESSENTIAL THROMBOCYTHEMIA, Archives of internal medicine, 155(11), 1995, pp. 1217-1222
Authors:
ANIA BJ
SUMAN VJ
SOBELL JL
CODD MB
SILVERSTEIN MN
MELTON LJ
Citation: Bj. Ania et al., TRENDS IN THE INCIDENCE OF POLYCYTHEMIA-VERA AMONG OLMSTED COUNTY, MINNESOTA RESIDENTS, 1935-1989, American journal of hematology, 47(2), 1994, pp. 89-93
Authors:
TEFFERI A
BARRETT SM
SILVERSTEIN MN
NAGORNEY DM
Citation: A. Tefferi et al., OUTCOME OF PORTAL-SYSTEMIC SHUNT SURGERY FOR PORTAL-HYPERTENSION ASSOCIATED WITH INTRAHEPATIC OBSTRUCTION IN PATIENTS WITH AGNOGENIC MYELOID METAPLASIA, American journal of hematology, 46(4), 1994, pp. 325-328
Authors:
TEFFERI A
SILVERSTEIN MN
Citation: A. Tefferi et Mn. Silverstein, RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA, British Journal of Haematology, 86(4), 1994, pp. 893-893
Authors:
PETRONE ME
SILVERSTEIN MN
WILSON J
PETITT RM
DEMENT MP
DEVINE CL
BISCARDI CA
HU WL
Citation: Me. Petrone et al., EFFECTS OF ANAGRELIDE HCI ON BLEEDING-TIME AND COAGULATION TESTS, Blood, 84(10), 1994, pp. 10000058-10000058
Authors:
TEFFERI A
SILVERSTEIN MN
PLUMHOFF EA
REID JM
AMES MM
Citation: A. Tefferi et al., SURAMIN TOXICITY AND EFFICACY IN AGNOGENIC MYELOID METAPLASIA, Journal of the National Cancer Institute, 85(18), 1993, pp. 1520-1522
Authors:
BERESSI AH
TEFFERI A
SILVERSTEIN MN
PETITT RM
HOAGLAND HC
Citation: Ah. Beressi et al., OUTCOME ANALYSIS OF 36 PREGNANCIES IN ESSENTIAL THROMBOCYTHEMIA, Blood, 82(10), 1993, pp. 10000383-10000383
Authors:
FAIRBANKS VF
HOYER JD
TEFFERI A
PETITT RM
SILVERSTEIN MN
Citation: Vf. Fairbanks et al., REQUIEM FOR THE CR-51 RED-CELL MASS - COST AND OUTCOME CONSIDERATIONS, Blood, 82(10), 1993, pp. 10000552-10000552
Risultati:
1-24
|